Nordea Investment Management AB Increases Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Nordea Investment Management AB raised its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 29.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 105,823 shares of the medical instruments supplier's stock after purchasing an additional 24,285 shares during the quarter. Nordea Investment Management AB owned 0.50% of Mettler-Toledo International worth $129,919,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of MTD. DT Investment Partners LLC raised its position in Mettler-Toledo International by 13.3% in the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after buying an additional 8 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Mettler-Toledo International by 8.0% in the third quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier's stock valued at $183,000 after purchasing an additional 9 shares during the last quarter. Suncoast Equity Management lifted its position in shares of Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier's stock valued at $690,000 after purchasing an additional 9 shares in the last quarter. Bleakley Financial Group LLC boosted its holdings in Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier's stock worth $1,135,000 after purchasing an additional 9 shares during the last quarter. Finally, Huntington National Bank grew its position in Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier's stock worth $81,000 after purchasing an additional 9 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on MTD. Citigroup upgraded Mettler-Toledo International from a "sell" rating to a "neutral" rating and boosted their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research note on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an "in-line" rating to an "outperform" rating and lifted their target price for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a "peer perform" rating for the company. Finally, Stifel Nicolaus dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $1,351.25.

Mettler-Toledo International Trading Up 0.2 %

Shares of NYSE MTD traded up $2.68 during midday trading on Tuesday, hitting $1,254.93. The company's stock had a trading volume of 130,046 shares, compared to its average volume of 112,362. The stock has a fifty day moving average price of $1,255.29 and a 200 day moving average price of $1,351.53. The firm has a market capitalization of $26.48 billion, a price-to-earnings ratio of 33.83, a P/E/G ratio of 4.21 and a beta of 1.12. Mettler-Toledo International Inc. has a one year low of $1,122.21 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the firm's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company's stock, valued at $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 140 shares of the company's stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.